FIELD: medicine.
SUBSTANCE: invention relates to the use of Triastin as a means of increasing the concentration of lactoferrin in the blood serum of the body.
EFFECT: increased concentration of lactoferrin in blood serum.
1 cl, 1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
MEDIATION INCREASING LEVEL OF LACTOFERRIN IN ORGANISM | 2012 |
|
RU2486894C1 |
PREPARATION MODULATING FERRITIN CONCENTRATION IN BLOOD SERUM | 2020 |
|
RU2749347C1 |
AGENT INCREASING FERRITIN CONCENTRATION IN HUMAN BLOOD SERUM | 2022 |
|
RU2794847C1 |
MEDICATION MODULATING CONCENTRATION OF FERRITIN IN BLOOD SERUM | 2012 |
|
RU2486895C1 |
METHOD FOR DIFFERENTIAL DIAGNOSTICS OF UREMIC PSEUDOPERITONITIS AND PERITONITIS IN PATIENTS RECEIVING RENAL REPLACEMENT THERAPY - PROGRAM HEMODIALYSIS | 2020 |
|
RU2761732C1 |
METHOD FOR DETERMINING TUBERCULOUS SPONDILITIS ACTIVITY DEGREE | 2004 |
|
RU2308723C2 |
METHOD FOR DIAGNOSING THE SEVERITY OF EPSTEIN-BARR VIRUS-INDUCED ACUTE INFECTIOUS MONONUCLEOSIS IN CHILDREN | 2022 |
|
RU2797960C1 |
DIAGNOSTIC TECHNIQUE FOR ACUTE CHOLECYSTITIS | 2009 |
|
RU2423706C1 |
DIAGNOSTIC TECHNIQUE FOR BACTERIAL ABDOMINAL SURGICAL INFECTION IN APPENDICITIS | 2023 |
|
RU2823995C1 |
DIAGNOSTIC TECHNIQUE OF APPENDIX CONDITION IN APPENDICULAR INFILTRATE | 2017 |
|
RU2691709C2 |
Authors
Dates
2021-03-15—Published
2020-07-27—Filed